Skip to main content

Table 2 Definition of outcomes and follow-up periods

From: Major adverse cardiac events and mortality in chronic obstructive pulmonary disease following percutaneous coronary intervention: a systematic review and meta-analysis

Outcomes

Definitions

Major adverse cardiac events (MACEs)

Defined as a combination of several outcomes including death, MI and revascularization

Death

Defined as all-cause mortality, that is, mortality due to any medical reason including cardiac and non-cardiac

Myocardial infarction (MI)

Defined as re-infarction that occurred post percutaneous coronary intervention based on two or more of the following: 1. Typical chest pain, 2. ECG showing ST-T or Q wave changes, 3. Increase in serum enzyme (creatinine kinase, lactate dehydrogenase or troponin), 4. New wall motion abnormalities on ultrasound

Coronary revascularization (CR)

Defined as repeated revascularization in the coronary arteries resulting in re-stenosis

In-hospital follow-up

Defined as the follow-up period during their hospital stay (≤ 1 month)

Long-term follow-up

Defined as the follow-up period of one or more years

  1. Abbreviations: ECG electrocardiogram